International Journal of Epidemiology, Volume 33, Number 1, pp. 10-11
IJE vol.33 no.1 © International Epidemiological Association 2004; all rights reserved.
Reprints and Reflections |
Commentary: Mendelian randomization, 18 years on
Wageningen Centre for Food Sciences and Division of Human Nutrition and Epidemiology, Wageningen University, Bomenweg 2, 6703 HD Wageningen, The Netherlands. E-mail: wcfs1@wur.nl
| The first 10% of the full text of this article appears below. |
I have no notes left regarding writing Apolipoprotein E isoforms, serum cholesterol, and cancer,1 but I think I thought it up in Hawaii. I passed through Hawaii on my way to the US from Melbourne, where I had given a talk on diet, low cholesterol, and cancer at the 7th International Atherosclerosis Symposium in October 1985. At that time the dangers of a low serum cholesterol level was a hot topic;2 several scientists thought that a low cholesterol increased your risk of violent death or cancer. This rested both on observational associations and on the outcomes of early cholesterol-lowering trials. The idea became less plausible after the big statin trials showed no relation between lowering of cholesterol and the rates of violent death or cancer, but those studies came later.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Trompet, J. W. Jukema, M. B. Katan, G. J. Blauw, N. Sattar, B. Buckley, M. Caslake, I. Ford, J. Shepherd, R. G. J. Westendorp, et al. Apolipoprotein E Genotype, Plasma Cholesterol, and Cancer: A Mendelian Randomization Study Am. J. Epidemiol., December 1, 2009; 170(11): 1415 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hunter, D. Altshuler, and D. J. Rader From Darwin's Finches to Canaries in the Coal Mine -- Mining the Genome for New Biology N. Engl. J. Med., June 26, 2008; 358(26): 2760 - 2763. [Full Text] [PDF] |
||||
![]() |
V. Didelez and N. Sheehan Mendelian randomization as an instrumental variable approach to causal inference Statistical Methods in Medical Research, August 1, 2007; 16(4): 309 - 330. [Abstract] [PDF] |
||||
![]() |
G. D. SMITH Mensuration, Mendel, and a 19th century public health justification for US imperialism Int. J. Epidemiol., August 1, 2006; 35(4): 811 - 813. [Full Text] [PDF] |
||||
![]() |
G. D. Smith, M. Gwinn, S. Ebrahim, L. J Palmer, and M. J Khoury Make it HuGE: human genome epidemiology reviews, population health, and the IJE Int. J. Epidemiol., June 1, 2006; 35(3): 507 - 510. [Full Text] [PDF] |
||||
![]() |
G. D. Smith Randomised by (your) god: robust inference from an observational study design J Epidemiol Community Health, May 1, 2006; 60(5): 382 - 388. [Full Text] [PDF] |
||||
![]() |
D. Nitsch, M. Molokhia, L. Smeeth, B. L. DeStavola, J. C. Whittaker, and D. A. Leon Limits to Causal Inference based on Mendelian Randomization: A Comparison with Randomized Controlled Trials Am. J. Epidemiol., March 1, 2006; 163(5): 397 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davey Smith and S. Ebrahim What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ, May 7, 2005; 330(7499): 1076 - 1079. [Full Text] [PDF] |
||||
![]() |
G. Davey Smith Genetic epidemiology: an 'enlightened narrative'? Int. J. Epidemiol., October 1, 2004; 33(5): 923 - 924. [Full Text] [PDF] |
||||
![]() |
M. J Khoury, R. Millikan, J. Little, and M. Gwinn The emergence of epidemiology in the genomics age Int. J. Epidemiol., October 1, 2004; 33(5): 936 - 944. [Full Text] [PDF] |
||||





